EYESTEM
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.
EYESTEM
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Bengaluru, Karnataka, India
Country:
India
Website Url:
http://www.eyestem.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investors List
Natco Pharma
Natco Pharma investment in Series A - Eyestem
Kotak Private Equity
Kotak Private Equity investment in Series A - Eyestem
Biological E.
Biological E. investment in Series A - Eyestem
Alkem Laboratories
Alkem Laboratories investment in Series A - Eyestem
Karan Bagaria
Karan Bagaria investment in Series A - Eyestem
Anurag Bagaria
Anurag Bagaria investment in Series A - Eyestem
Endiya Partners
Endiya Partners investment in Series A - Eyestem
Endiya Partners
Endiya Partners investment in Seed Round - Eyestem
Church Street Trustees
Church Street Trustees investment in Seed Round - Eyestem
Gillian Corken
Gillian Corken investment in Seed Round - Eyestem
Newest Events participated
Official Site Inspections
http://www.eyestem.com
- Host name: 26.137.66.148.host.secureserver.net
- IP address: 148.66.137.26
- Location: Singapore
- Latitude: 1.3667
- Longitude: 103.8
- Timezone: Asia/Singapore
More informations about "Eyestem"
Eyestem - Crunchbase Company Profile & Funding
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also …See details»
Eyestem Senior Management and Advisors | Eyestem
At Eyestem, she is involved in the development of iPSC-derived Retinal Pigment Epithelium (RPE) for the treatment of dry-AMD. Mamatha Jayagopal Senior Manager, Finance. Mamatha did her Masters in Finance from Annamalai …See details»
Eyestem - 2025 Company Profile, Funding
Mar 28, 2025 Eyestem is a series A company based in Bengaluru (India), founded in 2015 by Jogin Bhairav Desai, Rajani Ravindra Battu, Dhruv Sareen and Rajarshi Pal. It operates as a Developer of scalable cell replacement …See details»
Our Product Pipeline | Eyestem
Our Lead Asset. Eyecyte-RPE TM replaces lost retinal pigment epithelium cells. It is designed to restore sight for patients in the early stages of Age-Related Macular Degeneration and arrest losses for those in the later stages.See details»
Eyestem 2025 Company Profile: Valuation, Funding
Eyestem General Information Description. Developer of scalable cell replacement therapies designed to treat incurable diseases. The company's platform aims to replace damaged photoreceptor cells in the eye with healthy, transplantable …See details»
Eyestem - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Endiya Partners: Jul 25, …See details»
Eyestem Company Profile Funding & Investors
Eyestem is an innovative Bangalore based startup incubated at the Centre for Cellular and Molecular Platforms - a premier biotech incubator in the country. Dr. Jogin Desai, founder and CEO, was ...See details»
Eyestem - Contacts, Employees, Board Members, Advisors & Alumni
Eyestem is a cell therapy company founded by a top-class management team. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Eyestem is a trailblazing cell therapy company
Eyestem is a trailblazing cell therapy company led by a top-tier management team of clinical trials, cell therapy, and ophthalmology experts. Supported by a world-class advisory board and collaborations with industry pioneers, Eyestem …See details»
Eyestem - Products, Competitors, Financials, Employees, …
Eyestem to Start Human Trials for Its Pioneering Dry AMD Treatment. Apr 3, 2024. atment 03rd April 2024: Eyestem, a cell therapy company at the forefront of regenerative therapy, has …See details»
Eyestem Pioneers Scalable Cell Replacement Therapies for Global …
Sep 10, 2024 Eyestem is revolutionizing global healthcare by developing scalable, affordable cell replacement therapies for incurable diseases like AMD, RP, and IPFSee details»
Eyestem files for CDSCO approval for Eyecyte-RPE
Eyecyte-RPE will be used to treat geographic atrophy Eyestem Research announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards …See details»
Our Technology | Eyestem
About Us Our Technology . https://www.youtube.com/watch?v=z2OH4fGsY4M. About Us; Science; Publications; Collaborations; UpdatesSee details»
Eyestem completes first round of patient injections for its dry AMD ...
Aug 20, 2024 Eyestem Research Private Ltd hopes to shift the paradigm of ophthalmology in India with the completion of the first set of 3 patient injections for its RPE suspension therapy …See details»
#startupoftheday 153- Eyestem Research - BioSpectrum India
Eyestem intends to be the benchmark for quality and affordability in cells therapies for targeted conditions and expects to capture 1/6th of the global market. Have patents in India and the US …See details»
Eyestem: A Vision For The Future - Forbes India
Oct 11, 2023 The first product Eyestem is developing is to treat a condition called dry age-related macular degeneration, the largest cause of incurable blindness for people over 50 in …See details»
Eyestem - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 10, 2025 Organization. Eyestem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly …See details»
Eyestem’s Eyecyte-RPE™ Trial Shows Vision Rescue for
6 days ago Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10 th Retinal Cell and Gene Therapy Innovation Summit in early May. For more information, …See details»
What's happening at Eyestem | Eyestem
National, (Date) - Eyestem, a cell therapy company at the forefront of regenerative therapy, has received approval from India’s Central Drugs Standards Control Organisation (CDSCO) to …See details»
India-based Eyestem receives approval to commence human trial …
Apr 14, 2024 Eyestem’s Eyecyte RPE therapy aims to replace lost or damaged Retinal Pigment Epithelium (RPE) cells, which is a shift in tackling the disease. The goal is to preserve and …See details»